We have been told that IMU was going to be a licensing and royalties company, this to me is a change of business direction because they have seen huge indications with CF33, I now believe IMU will be a Goliath in the Oncology pharmaceutical company space.
I hope all loyal holders get a chance to participate because I certainly will load up more.
Ann: Imugene Licenses Allogeneic CD19 CAR T Cell Therapy, page-41
-
- There are more pages in this discussion • 466 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
-0.002(3.39%) |
Mkt cap ! $440.9M | |||
| Open | High | Low | Value | Volume |
| 6.0¢ | 6.2¢ | 5.7¢ | $1.393M | 23.20M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 1627226 | 5.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 883971 | 24 |
View Market Depth
| Last trade - 12.39pm 15/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |